NeoGiANT (2021–2026) directly investigates grape extract polyphenols as natural antimicrobial and antioxidant agents to reduce antibiotic use in animal treatment and feed.
INSTYTUT BIOTECHNOLOGII PRZEMYSLU ROLNO-SPOZYWCZEGO IM PROF WACLAWA DABROWSKIEGO - PANSTWOWY INSTYTUT BADAWCZY
Polish state food biotechnology institute specializing in natural antimicrobials, polyphenols, and microbial resource management for food and animal health.
Their core work
IBPRS is a Polish state research institute specializing in agricultural and food biotechnology, operating under the patronage of Prof. Wacław Dąbrowski. Their practical work spans two distinct but related domains: the preservation and governance of microbial diversity (maintaining culture collections, navigating biosecurity and access regulations), and the development of natural antimicrobial and antioxidant compounds — particularly from grape-derived polyphenols — as replacements for antibiotics in animal husbandry and food production. They contribute applied science: testing bioactive plant compounds in real veterinary contexts such as mastitis treatment and sperm extenders for animal reproduction. Their positioning bridges food safety, microbiology, and animal health, making them a specialist partner when natural alternatives to synthetic preservatives or antibiotics are needed.
What they specialise in
IS_MIRRI21 (2020–2023) focused on sustaining microbial resource research infrastructure, preserving microbial diversity, and implementing the Nagoya Protocol on access and benefit sharing.
NeoGiANT covers antimastitis formulations and sperm extender applications, indicating hands-on expertise in veterinary-facing biotechnology beyond food processing.
IS_MIRRI21 work included biosecurity protocols and Nagoya Protocol compliance — niche expertise relevant to any consortium handling biological materials across EU borders.
NeoGiANT's focus on enhanced feed with polyphenols and bioactive compounds points toward functional ingredient development for the food and feed industry.
How they've shifted over time
IBPRS entered H2020 through the microbiology governance route — their first project (IS_MIRRI21, 2020) was about infrastructure, diversity preservation, and regulatory compliance around biological resources, including the Nagoya Protocol. This reflects a strong institutional tradition in culture collection management and applied microbiology. Their second project (NeoGiANT, 2021) marks a clear pivot toward applied natural chemistry: polyphenols, plant-derived antimicrobials, and antibiotic alternatives for animal production. The trajectory moves from "preserving and governing biological resources" toward "exploiting natural bioactive compounds to solve practical food and veterinary problems" — a shift from policy-adjacent science toward market-relevant R&D.
IBPRS is moving toward applied natural product science — specifically antibiotic alternatives from plant sources — which positions them well for the growing EU regulatory push to reduce antimicrobial resistance in livestock and food production.
How they like to work
IBPRS has participated exclusively as a consortium partner across both projects, never taking the coordinator role — consistent with a specialist institute that brings focused laboratory expertise rather than project management capacity. Despite only two projects, they have engaged with 40 unique partners across 14 countries, suggesting they are embedded in active, broad international consortia rather than working in narrow bilateral partnerships. They appear to function as a trusted specialist contributor: brought in for specific technical capabilities (microbial work, bioactive compound testing) within larger coordinated efforts.
With 40 unique consortium partners across 14 countries from just two projects, IBPRS has a surprisingly wide network relative to their H2020 footprint — both projects placed them in large, multi-country research consortia spanning most of the EU and beyond. No geographic concentration is evident; their partnerships appear driven by thematic fit rather than regional proximity.
What sets them apart
IBPRS occupies an unusual niche at the intersection of food biotechnology, microbiology infrastructure, and veterinary applications — a combination rarely found in a single institute. Their state institute status in Poland gives them credibility with regulatory bodies and access to established biological collections, while their NeoGiANT work demonstrates they can translate natural compound research into concrete veterinary product prototypes (mastitis treatment, sperm extenders). For consortium builders targeting antibiotic reduction in food production or animal health, IBPRS offers both the scientific depth in bioactive compounds and the institutional weight of a nationally-recognized research body.
Highlights from their portfolio
- NeoGiANTThe largest and longest of their projects (EUR 426,488, running to 2026), it tackles antibiotic resistance in livestock through grape polyphenols — a commercially relevant topic directly linked to EU One Health policy and food safety regulation.
- IS_MIRRI21Participation in a pan-European microbial research infrastructure project signals IBPRS's role in Poland's national microbial collection system and their standing within the broader European research infrastructure community.